FDA NDC Directory · JSON-LD · Markdown

EXPAREL

NDC 65250-266 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION, LIPOSOMAL

Generic namebupivacaine
Labeler / ManufacturerPacira Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022496
Dosage form / routeINJECTION, SUSPENSION, LIPOSOMAL · INFILTRATION
Active ingredientsBUPIVACAINE (13.3 mg/mL)
Marketing started20120101
Package count2

External sources

Source: openFDA. Public-domain (CC0).